Glycorex Transplantation Balance Sheet Health
Financial Health criteria checks 4/6
Glycorex Transplantation has a total shareholder equity of SEK38.3M and total debt of SEK744.0K, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are SEK58.7M and SEK20.4M respectively.
Key information
1.9%
Debt to equity ratio
SEK 744.00k
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 7.85m |
| Equity | SEK 38.30m |
| Total liabilities | SEK 20.43m |
| Total assets | SEK 58.73m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: GTAB B's short term assets (SEK22.3M) exceed its short term liabilities (SEK14.7M).
Long Term Liabilities: GTAB B's short term assets (SEK22.3M) exceed its long term liabilities (SEK5.7M).
Debt to Equity History and Analysis
Debt Level: GTAB B has more cash than its total debt.
Reducing Debt: GTAB B's debt to equity ratio has increased from 0% to 1.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GTAB B has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: GTAB B has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.6% each year